A Preoperative Echocardiographic Predictive Model for Assessment of Cardiovascular Outcome after Renal Transplantation

Journal of the American Society of Echocardiography

Volumn 23, Issue 5, 2010, Pages 560-566

  Cai, Qiangjun ^a   Serrano, Ricardo ^a   Kalyanasundaram, Arun ^a   Shirani, Jamshid ^a  

^a GEISINGER MEDICAL CENTER   (United States)

Author keywords

Coronary artery disease; Dobutamine stress echocardiography; Major adverse cardiac event; Preoperative risk stratification; Renal transplantation

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ATROPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOBUTAMINE;

ACUTE HEART INFARCTION; ADULT; ANGIOCARDIOGRAPHY; AORTA ATHEROSCLEROSIS; ARTICLE; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DYSLIPIDEMIA; FEMALE; GENDER BIAS; HEART ATRIUM ENLARGEMENT; HEART DEATH; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERIPHERAL VASCULAR DISEASE; PREDICTION; PREOPERATIVE EVALUATION; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; SMOKING; STRESS ECHOCARDIOGRAPHY;

COMORBIDITY; DEATH, SUDDEN, CARDIAC; ECHOCARDIOGRAPHY; FEMALE; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PENNSYLVANIA; PREOPERATIVE CARE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS;

EID: 77951666130     PISSN: 08947317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.echo.2010.03.008     Document Type: Article

References (55)

1. Kassiske B.L., Guijarro C., Massy G.A., Wiederkehr M.R., and Ma J.Z. Cardiovascular disease after renal transplantation. J Am Soc Nephrol 7 (1996) 158-165
2. Ojo A.O., Hanson J.A., Wolfe R.A., Leichtman A.B., Agodoa L.Y., and Port F.K. Long-term survival in renal transplant recipients with graft function. Kidney Int 57 (2000) 307-313
3. Kasiske B.L., Cangro C.B., Hariharan S., Hricik D.E., Kerman R.H., Roth D., et al. The evaluation of renal transplantation candidates: clinical practice guidelines. Am J Transplant 1 Suppl 2 (2001) 3-95
4. Marwick T.H., Lauer M.S., Lobo A., Nally J., and Braun W. Use of dobutamine echocardiography for cardiac risk stratification of patients with chronic renal failure. J Intern Med 244 (1998) 155-161
5. Rakhit D.J., Armstrong K.A., Beller E., Isbel N.M., and Marwick T.H. Risk stratification of patients with chronic kidney disease: results of screening strategies incorporating clinical risk scoring and dobutamine stress echocardiography. Am Heart J 152 (2006) 363-370
6. Bergeron S., Hillis G.S., Haugen E.N., Oh J.K., Bailey K.R., and Pellikka P.A. Prognostic value of dobutamine stress echocardiography in patients with chronic kidney disease. Am Heart J 153 (2007) 385-391
7. Bart B.A., Cen Y.Y., Hendel R.C., Lee R., Marwick T.H., Missov E.D., et al. Comparison of dobutamine stress echocardiography, dobutamine SPECT, and adenosine SPECT myocardial perfusion imaging in patients with end-stage renal disease. J Nucl Cardiol 16 (2009) 507-515
8. Reis G., Marcovitz P.A., Leichtman A.B., Merion R.M., Fay W.P., Werns S.W., et al. Usefulness of dobutamine stress echocardiography in detecting coronary artery disease in end-stage renal disease. Am J Cardiol 75 (1995) 707-710
9. Bates J.R., Sawada S.G., Segar D.S., Spaedy A.J., Petrovic O., Fineberg N.S., et al. Evaluation using dobutamine stress echocardiography in patients with insulin-dependent diabetes mellitus before kidney and/or pancreas transplantation. Am J Cardiol 77 (1996) 175-179
10. Brennan D.C., Vedala G., Miller S.B., Anstey M.E., Singer G.G., Kovacs A., et al. Pretransplantation dobutamine stress echocardiography is useful and cost-effective in renal transplant candidates. Transplant Proc 29 (1997) 233-234
11. Herzog C.A., Marwick T.H., Pheley A.M., White C.W., Rao V.K., and Dick C.D. Dobutamine stress echocardiography for the detection of significant coronary artery disease in renal transplant candidates. Am J Kidney Dis 33 (1999) 1080-1090
12. West J.C., Napoliello D.A., Costello J.M., Nassef L.A., Butcher R.J., Hartle J.E., et al. Preoperative dobutamine stress echocardiography versus cardiac arteriography for risk assessment prior to renal transplantation. Transpl Int 13 Suppl 1 (2000) S27-S30
13. De Lima J.J., Sabbaga E., Vieira M.L., de Paula F.J., Ianhez L.E., Krieger E.M., et al. Coronary angiography is the best predictor of events in renal transplant candidates compared with noninvasive testing. Hypertension 42 (2003) 263-268
14. Sharma R., Pellerin D., Gaze D.C., Gregson H., Streather C.P., Collinson P.O., et al. Dobutamine stress echocardiography and the resting but not exercise electrocardiograph predict severe coronary artery disease in renal transplant candidates. Nephrol Dial Transplant 20 (2005) 2207-2214
15. Sharma R., Pellerin D., Gaze D.C., Shah J.S., Streather C.P., Collinson P.O., et al. Dobutamine stress echocardiography and cardiac troponin T for the detection of significant coronary artery disease and predicting outcome in renal transplant candidates. Eur J Echocardiogr 6 (2005) 327-335
16. Gang S., Dabhi M., and Rajapurkar M.M. Ischaemia imaging in type 2 diabetic kidney transplant candidates-is coronary angiography essential?. Nephrol Dial Transplant 22 (2007) 2334-2338
17. Sharma R., Mehta R.L., Brecker S.J.D., Gaze D.C., Gregson H., Streather C.P., et al. The diagnostic and prognostic value of tissue Doppler imaging during dobutamine stress echocardiography in end-stage renal disease. Coron Artery Dis 20 (2009) 230-237
18. Dussol B., Bonnet J.L., Sampol J., Savin B., De La Forte C., Mundler O., et al. Prognostic value of inducible myocardial ischemia in predicting cardiovascular events after renal transplantation. Kidney Int 66 (2004) 1633-1639
19. Tita C., Karthikeyan V., Store A., Jacobson G., and Ananthasubramaniam K. Stress echocardiography for risk stratification in patients with end-stage renal disease undergoing renal transplantation. J Am Soc Echocardiogr 21 (2008) 321-326
20. Lin K., Stewart D., Cooper S., and Davis C.L. Pre-transplant cardiac testing for kidney-pancreas transplant candidates and association with cardiac outcomes. Clin Transplant 15 (2001) 269-275
21. Devereux R.B., Alonso D.R., Lutas E.M., Gottlieb G.J., Campo E., Sachs I., et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57 (1986) 450-458
22. Go A.S., Chertow G.M., Fan D., McCulloch C.E., and Hsu C.Y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351 (2004) 1296-1305
23. Parfrey P.S., and Foley R.N. The clinical epidemiology of cardiac disease in chronic renal failure. J Am Soc Nephrol 10 (1999) 1606-1615
24. McCullough P.A. Contrast-induced acute kidney injury. J Am Coll Cardiol 51 (2008) 1419-1428
25. Russo D., Corrao S., Miranda I., Ruocco C., Manzi S., Elefante R., et al. Progression of coronary artery calcification in predialysis patients. Am J Nephrol 27 (2007) 152-158
26. Schwarz U., Buzello M., Ritz E., Stein G., Raabe G., Wiest G., et al. Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure. Nephrol Dial Transplant 15 (2000) 218-223
27. Amann K. Media calcification and intima calcification are distinct entities in chronic kidney disease. Clin J Am Soc Nephrol 3 (2008) 1599-1605
28. Schietinger B.J., Brammer G.M., Wang H., Christopher J.M., Kwon K.W., Mangrum A.J., et al. Patterns of late gadolinium enhancement in chronic hemodialysis patients. JACC Cardiovasc Imaging 1 (2008) 450-456
29. Rofsky N.M. Nephrogenic systemic fibrosis: considerations for the cardiologist. JACC Cardiovasc Imaging 1 (2008) 457-459
30. Marwick T.H., Steinmuller D.R., Underwood D.A., Hobbs R.E., Go R.T., Swift C., et al. Ineffectiveness of dipyridamole SPECT thallium imaging as a screening technique for coronary artery disease in patients with end-stage renal failure. Transplantation 49 (1990) 100-103
31. Vandenberg B.F., Rossen J.D., Grover-McKay M., Shammas N.W., Burns T.L., and Rezai K. Evaluation of diabetic patients for renal and pancreas transplantation: noninvasive screening for coronary artery disease using radionuclide methods. Transplantation 62 (1996) 1230-1235
32. Kasiske B.L., Vazquez M.A., Harmon W.E., Brown R.S., Danovitch G.M., Gaston R.S., et al. Recommendations for the outpatient surveillance of renal transplant recipients. J Am Soc Nephrol 11 suppl 15 (2000) S1-S86
33. Wolfe R.A., Ashby V.B., Milford E.L., Ojo A.O., Ettenger R.E., Agodoa L.Y.C., et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 341 (1999) 1725-1730
34. Wali R.K., Wang G.S., Gottlieb S.S., Bellumkonda L., Hansalia R., Ramos E., et al. Effect of kidney transplantation on left ventricular systolic dysfunction and congestive heart failure in patients with end-stage renal disease. J Am Coll Cardiol 45 (2005) 1051-1060
35. Kessler M., Zannad F., Lehert P., Grünfeld J.P., Thuilliez C., Leizorovicz A., et al. Predictors of cardiovascular events in patients with end-stage renal disease: an analysis from the Fosinopril in dialysis study. Nephrol Dial Transplant 22 (2007) 3573-3579
36. Sharma R., Chemla E., Tome M., Mehta R.L., Gregson H., Brecker S., et al. Echocardiography-based score to predict outcome after renal transplantation. Heart 93 (2007) 464-469
37. Weinrauch L.A., D'Elia J.A., Monaco A.P., Gleason R.E., Welty F., Nishan P.C., et al. Preoperative evaluation for diabetic renal transplantation: impact of clinical, laboratory, and echocardiographic parameters on patient and allograft survival. Am J Med 93 (1992) 19-28
38. Zoccali C., Benedetto F.A., Mallamaci F., Tripepi G., Giacone G., Cataliotti A., et al. Prognostic value of echocardiographic indicators of left ventricular systolic function in asymptomatic dialysis patients. J Am Soc Nephrol 15 (2004) 1029-1037
39. Hayashi S.Y., Rohani M., Lindholm B., Brodin L.A., Lind B., Barany P., et al. Left ventricular function in patients with chronic kidney disease evaluated by colour tissue Doppler velocity imaging. Nephrol Dial Transplant 21 (2006) 125-132
40. Sharma R., Pellerin D., Gaze D.C., Mehta R.L., Gregson H., Streather C.P., et al. Mitral peak Doppler E-wave to peak mitral annulus velocity ratio is an accurate estimate of left ventricular filling pressure and predicts mortality in end-stage renal disease. J Am Soc Echocardiogr 19 (2006) 266-273
41. Hsiao S.H., Huang W.C., Chiou K.R., Lee C.Y., Yang S.H., Wang W.C., et al. Major events in uremic patients: insight from parameters derived by flow propagation velocity. J Am Soc Echocardiogr 21 (2008) 741-746
42. Wang A.Y., Wang M., Lam C.W., Chan I.H., Zhang Y., and Sanderson J.E. Left ventricular filling pressure by Doppler echocardiography in patients with end-stage renal disease. Hypertension 52 (2008) 107-114
43. Tripepi G., Benedetto F.A., Mallamaci F., Tripepi R., Malatino L., and Zoccali C. Left atrial volume monitoring and cardiovascular risk in patients with end-stage renal disease: a prospective cohort study. J Am Soc Nephrol 18 (2007) 1316-1322
44. Barberato S.H., and Pecoits-Filho R. Usefulness of left atrial volume for the differentiation of normal from pseudonormal diastolic function pattern in patients on hemodialysis. J Am Soc Echocardiogr 20 (2007) 359-365
45. Tripepi G., Mattace-Raso F., Mallamaci F., Benedetto F.A., Witteman J., Malatino L., et al. Biomarkers of left atrial volume. A longitudinal study in patients with end stage renal disease. Hyperetension 54 (2009) 818-824 Epub 2009 Jul 27
46. Joki N., Hase H., Saijyo T., Tanaka Y., Takahashi Y., Ishikawa H., et al. Combined assessment of cardiac systolic dysfunction and coronary atherosclerosis used to predict future cardiac deaths after starting hemodialysis. Am J Nephrol 23 (2003) 458-465
47. Otto C.M., Lind B.K., Kitzman D.W., Gersh B.J., and Siscovick D.S. The cardiovascular HS. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med 341 (1999) 142-147
48. Aronow W.S., Ahn C., Shirani J., and Kronzon I. Comparison of frequency of new coronary events in older subjects with and without valvular aortic sclerosis. Am J Cardiol 83 (1999) 599-600
49. Chandra H.R., Goldstein J.A., Choudhary N., O'Neill C.S., George P.B., Gangasani S.R., et al. Adverse outcome in aortic sclerosis is associated with coronary artery disease and inflammation. J Am Coll Cardiol 43 (2004) 169-175
50. Taylor Jr. H.A., Clark B.L., Garrison R.J., Andrew M.E., Han H., Fox E.R., et al. Relation of aortic valve sclerosis to risk of coronary heart disease in African-Americans. Am J Cardiol 95 (2005) 401-404
51. Stewart B.F., Siscovick D., Lind B.K., Gardin J.M., Gottdiener J.S., Smith V.E., et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol 29 (1997) 630-634
52. Maher E.R., Young G., Smyth-Walsh B., Pugh S., and Curtis J.R. Aortic and mitral valve calcification in patients with end-stage renal disease. Lancet 2 (1987) 875-877
53. Assal C., Martin B., Serrano R., McConnell T., and Shirani J. Coronary atherosclerosis risk assessment using two-dimensional echocardiography. [abstract]. Eur J Echocardiographr (2009) (in press)
54. Fellström B.C., Jardine A.G., Schmieder R.E., et al. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med 360 (2009) 1395-1407
55. Tripepi G., Benedetto F.A., Mallamaci F., Tripepi R., Malatino L., and Zoccali C. Left atrial volume monitoring and cardiovascular risk in patients with end-stage renal disease: a prospective cohort study. J Am Soc Nephrol 18 (2007) 1316-1322